Dan Niles, founder and portfolio manager of Niles Investment Management, discusses the recent downturn in chip stocks, particularly ASML’s warning about weak sales in China. He examines if the semiconductor surge has peaked and where potential investment opportunities might lie. Sarah James, Managing Director at Cantor Fitzgerald, analyzes UnitedHealth's troubling earnings report, emphasizing rising medical costs and its worst day since the pandemic, sparking discussions about future strategies in the healthcare sector.
